13,278 research outputs found
Ms. Courtney Chartier, RWWL AUC, August 2011
No full textThis video is a conversation with Ms. Courtney Chartier. Ms. Chartier talks about her work on the "New Georgia Encyclopedia" and "Online Voter Education Project." Andrea Jackson, AUC Woodruff Library, is the interviewer
Ms. Neely Terrell, RWWL AUC, March 2012
No full textThis video is a conversation with Ms. Neely Terrell. Ms. Terrell talks about her book, "Super Singles Activate". Anthony Kinsey and Jahnesta Horney, AUC Woodruff Library, are the interviewers
Ms. Felesha Love, Spelman College, January 2016
No full textThis video is a conversation with Felesha Love. Ms. Love talks about her book, "Brave Leap to Freedom: Integrating Mind, Body, and Spirit to Cultivate Healthy Relationships". Jordan Moore, AUC Woodruff Library, is the interviewer
Assessment of Nili-Ravi buffalo (Bubalus bubalis) semen by MTT reduction assay
No full textMTT (3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay is commonly used to validate the viability of metabolically active cells. The study was conducted to examine and validate the MTT test to assess the sperm viability of Nili-Ravi buffalo bulls and compare the efficiency of the test with the supra-vital staining technique (eosin-nigrosine) and hypo-osmotic swelling test. Fresh semen samples from breeding Nili-Ravi buffalo bulls (n = 20) were collected using an artificial vagina. After assessing the quality of semen for normal parameters, the MTT assay was carried out in phosphate buffer saline. Results revealed a high significant correlation (r = 0.995) between the viability of sperm and the rate of reduction of MTT. The other proportions of some semen samples showed a weak relationship between the eosinnigrosine method (r = -0.32), hypo-osmotic swelling test (r = -0.12) and motility (r = -0.08). However, the MTT assay was found to be superior to other tests as it was able to determine those sperm which were more than 90% viable. In conclusion, the MTT assay is a simple, robust test that can be used to select Nili-Ravi buffalo bulls on the basis of sperm quality.Keywords: MTT, Nili-Ravi, buffalo, sperm, viabilit
Innovation, Big Data, and Collaboration: Improving Population Health
No full textDr. Somesh Nigam is Senior Vice President and Chief Informatics Officer, and Ravi Chawla, MS, MBA is Director Client Solutions at Independence Blue Cross (IBC). Through the implementation of innovative technology, the Informatics Division of IBC plays critical role to its stakeholders and associates.
Dr. Nigam and Mr. Chawla will provide an overview of informatics and population health with emphasis on special initiatives of IBC. They will explore ways in which technology can be used to “tell a story” and describe methods and technologies that help consumers and providers in decision making. They will also highlight the components of predictive analytics as a model for improving care and decreasing costs.
Presentation: 52 minutes
No Powerpoint slides with this presentatio
Valproaadi metaboolsed mõjud epilepsiaga patsientidel akuutse ja kroonilise ravi puhul
No full textVäitekirja elektrooniline versioon ei sisalda publikatsioone.Valproaat (VPA) on maailmas laialt kasutatav epileptiliste hoogude kontrollimiseks mõeldud preparaat, mida erinevatel hinnangutel kasutab iga päev rohkem kui üks miljon inimest. Üheks kõige sagedasemaks VPA kõrvaltoimeks peetakse kehakaalu tõusu. Sellega võivad sageli kaasneda metaboolsed ja endokriinsed häired, mida hästi kirjeldab metaboolse sündroomi (MS) kontseptsioon. Vähesed uuringuid, mis kirjeldavad MS-i levimust ja riskifaktoreid VPA-d tarvitavatel patsientidel on andnud vastuolulisi tulemusi. Ei ole ka täpselt teada VPA-st tingitud kaalutõusu molekulaarsed mehhanismid. Käesoleva uuringu eesmärkideks oli hinnata MS-i ja selle komponentide levimust VPA-d tarvitavatel epilepsiaga inimestel, võrrelda seda üldpopulatsiooni ja teist antikonvulsanti - karbamasepiini (CBZ) tarvitavate patsientidega, iseloomustada veeni manustatava VPA akuutset mõju glükoosi vere kontsentratsioonile ning kirjeldada VPA kroonilise ravi toimet geeniekspressioonile esmaselt diagnoositud epilepsiaga patsientidel. Uuringus leiti, et MS-i levimus VPA-monoteraapial olevatel patsientidel on 25.8%, mis oluliselt ei erine MS-i levimusest Eesti üldpopulatsioonis ja CBZ tarvitavatel patsientidel. Samas, VPA-d tarvitavatel naistel on MS-i risk tendentsina kõrgem kui meestel. Seega, naistel, kellel juba enne ravi algust esineb kõrgem südame-veresoonkonna haiguste risk, ei ole VPA kasutamine ekvivalentse alternatiivi olemasolul soovitav. Pikem VPA ravi kestus ja kõrgem annus tõstsid samuti MS-i riski. Üllatavalt madal geenide transkriptsiooni aktivatsiooni tase meie uuringus on tingitud tõenäoliselt suhteliselt madalatest kasutatud VPA annustest. Järelikult, muutunud geenide ekspressiooniga seotud kõrvaltoimete tõenäosuse vähendamiseks on soovitav kasutada võimalikult väikest VPA annust. Pärast veenisisese VPA manustamist, glükoositaluvuse testi käigus, langes patsientidel plasma glükoosi kontsentratsioon. VPA otsene hüpogükeemiline toime ja sellega kaasnev võimalik söögiisu suurenemine võib seletada kaalu muutusi VPA-d tarvitavatel patsientidel. Antud töö tulemused annavad lisainformatsiooni VPA-raviga seotud riskidest ning aitavad ohutumalt kasutada seda efektiivset antikonvulsanti.Valproate (VPA) is one of the most frequently prescribed antiepileptic drugs (AEDs), with more than one million people around the world estimated to be taking VPA every day. One of the most common side effects of VPA treatment is weight gain, which could be associated with important metabolic and endocrine abnormalities. However, only a few studies, with conflicting results, have examined the presence of metabolic syndrome (MS) in VPA-treated patients with epilepsy. The precise pathogenic mechanism underlying VPA-induced weight gain is also still unclear. The aims of the current study were to estimate the prevalence of MS and its components among people with epilepsy treated with VPA, to compare it to the general population, and to the people with epilepsy treated with other AED – carbamazepine (CBZ), as well as to describe the effect of acute intravenous VPA treatment on the blood levels of glucose and the influence of chronic VPA treatment on the gene expression in patients with epilepsy. We found that that the prevalence of MS in patients with epilepsy who received VPA treatment was 25.8%, which did not differ from the Estonian general population and CBZ-treated patients. However, females treated with VPA tended to have a higher risk of MS compared to males. Therefore, in females with a higher risk of cardiovascular diseases, AEDs other than VPA could be considered first. Longer duration of VPA treatment and higher dose also tended to increase the risk of MS. The surprisingly small number of genes, which were differently expressed before and after the start of VPA treatment, is explained by the relatively low doses of VPA that were used. Therefore, to minimize the potential side effects of increased gene expression, it is recommended that the lowest effective dose of VPA be used for treating epilepsy. Intravenous VPA administration decreased glucose levels during oral glucose tolerance test directly following the initial VPA exposure. This finding could explain an increased appetite in VPA-treated patients that results in weight gain. The results of our study provide additional information about the risks related to the VPA treatment, which helps to use this effective AED more safely
Social Media in Tourism A Double Edged Sword
No full textExtensive spread of the Internet and speedy technological advancement have revolutionized all industries in the World specifically tourism. The presence of the information and communication technology have fundamentally change the way how tourists collect detailed information, how do they can carefully map decision substitutes, how they book their travel and how they share their unique travel experience with others. A vital step forward in the progress of the internet has been made by a noteworthy growth in the popularity of social media platforms. Social media plays a very important role in tourism which is an information based industry. Consumers need information that can assist them in the process of travel planning and making decisions related to selection of tourism destination and other travel related products. Social media has also extended the reach of industry as now they can easily target consumers sitting far away without even meeting them. Destination marketer use social media before the travel so as to engage and inform the tourists, during the travel so as to facilitate at destination and after the travel to remember and share experiences. But social media in tourism marketing can be both an aid and a threat as social media influences the tourism industry both in positive and negative ways, as the decisions of prospective travellers have been strongly affected by comments and personal experiences of other users on social media. The main objective of the paper is to understand the relationship between social media and destination marketing and to examine the positive and negative impact of social media marketing in tourism industry. Ms. Priyanka Sharma | Mr. Ravi Kumar | Ms. Asha Rani "Social Media in Tourism- A Double-Edged Sword" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-1 , December 2017, URL: https://www.ijtsrd.com/papers/ijtsrd8222.pd
Étude sur le patois de Valbonnais
No full textA lexical and morphologic description of Valbonnais dialect. A 319-page PhD dissertation under the direction of Prof. Antonin DURAFFOUR (Univ. Stendhal, Grenoble, France, 1943)Description lexicale et morphologique du patois de Valbonnais sous la forme d'un manuscrit de 319 pages.Thèse sous la direction du Prof. Antonin DURAFFOUR (Univ. Stendhal, Grenoble, 1943
sj-docx-1-wso-10.1177_17474930241245612 – Supplemental material for A randomized controlled trial of medication adherence and management of risk factors for secondary prevention of stroke (MaMoRS) using a smartphone-based application
No full textSupplemental material, sj-docx-1-wso-10.1177_17474930241245612 for A randomized controlled trial of medication adherence and management of risk factors for secondary prevention of stroke (MaMoRS) using a smartphone-based application by Veena Babu, PN Sylaja, Biju Soman, Ravi Prasad Varma, Manju MS, Geethu GL and Suresh Kumar B in International Journal of Stroke</p
Radar Chart of Citation topic Meso, source: Formulated by author using MS Excel (2016).
No full textRadar Chart of Citation topic Meso, source: Formulated by author using MS Excel (2016).</p
- …
